These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17430167)

  • 1. Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?
    Kraaijeveld AO; de Jager SC; van Berkel TJ; Biessen EA; Jukema JW
    Curr Pharm Des; 2007; 13(10):1039-52. PubMed ID: 17430167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines as therapeutic targets for atherosclerotic plaque destabilization and rupture.
    Daissormont IT; Kraaijeveld AO; Biessen EA
    Future Cardiol; 2009 May; 5(3):273-84. PubMed ID: 19450053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of atherosclerotic plaque inflammation.
    Bäck M; Weber C; Lutgens E
    J Intern Med; 2015 Nov; 278(5):462-82. PubMed ID: 25823439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targeting of chemokine interactions in atherosclerosis.
    Koenen RR; Weber C
    Nat Rev Drug Discov; 2010 Feb; 9(2):141-53. PubMed ID: 20118962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines and atherosclerosis.
    Sheikine Y; Hansson GK
    Ann Med; 2004; 36(2):98-118. PubMed ID: 15119830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the chemokine network in atherosclerosis.
    Yan Y; Thakur M; van der Vorst EPC; Weber C; Döring Y
    Atherosclerosis; 2021 Aug; 330():95-106. PubMed ID: 34247863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines as Therapeutic Targets in Cardiovascular Disease.
    Noels H; Weber C; Koenen RR
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):583-592. PubMed ID: 30760014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory Chemokines in Atherosclerosis.
    Gencer S; Evans BR; van der Vorst EPC; Döring Y; Weber C
    Cells; 2021 Jan; 10(2):. PubMed ID: 33503867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical Chemokine Receptors in Cardiovascular Disease.
    Gencer S; van der Vorst EPC; Aslani M; Weber C; Döring Y; Duchene J
    Thromb Haemost; 2019 Apr; 119(4):534-541. PubMed ID: 30716778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines as novel therapeutic targets in inflammatory diseases.
    Ajuebor MN; Swain MG; Perretti M
    Biochem Pharmacol; 2002 Apr; 63(7):1191-6. PubMed ID: 11960595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines in atherosclerosis: proceedings resumed.
    Zernecke A; Weber C
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):742-50. PubMed ID: 24436368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of atherosclerotic plaque instability and rupture.
    Koenig W; Khuseyinova N
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):15-26. PubMed ID: 17082488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilizing the vulnerable plaque: the search for the magic bullet.
    Pasterkamp G; Daemen M
    Curr Pharm Des; 2007; 13(10):979-82. PubMed ID: 17430161
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemokines in atherosclerosis: an update.
    Zernecke A; Shagdarsuren E; Weber C
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1897-908. PubMed ID: 18566299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease.
    Anders HJ; Vielhauer V; Schlöndorff D
    Kidney Int; 2003 Feb; 63(2):401-15. PubMed ID: 12631106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractalkine--a local inflammatory marker aggravating platelet activation at the vulnerable plaque.
    Flierl U; Schäfer A
    Thromb Haemost; 2012 Sep; 108(3):457-63. PubMed ID: 22739755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease.
    Sedding DG; Boyle EC; Demandt JAF; Sluimer JC; Dutzmann J; Haverich A; Bauersachs J
    Front Immunol; 2018; 9():706. PubMed ID: 29719532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression.
    Wezel A; Lagraauw HM; van der Velden D; de Jager SC; Quax PH; Kuiper J; Bot I
    Atherosclerosis; 2015 Aug; 241(2):289-96. PubMed ID: 26062988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects.
    Eriksson EE
    Curr Opin Lipidol; 2004 Oct; 15(5):553-8. PubMed ID: 15361791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating the role of chemokines in inflammaging associated atherosclerotic cardiovascular diseases.
    Nagar N; Naidu G; Panda SK; Gulati K; Singh RP; Poluri KM
    Mech Ageing Dev; 2024 Aug; 220():111944. PubMed ID: 38782074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.